The Latin America, Middle East and Africa Nebulizer Market would witness market growth of 8% CAGR during the forecast period (2022-2028). In terms of administering medication, nebulizers are often simpler to use than other delivery methods. However, it may take a nebulizer up to ten minutes to distribute the drug, and the user is required to stay motionless until they have breathed all of it. This may be difficult for a small kid to do. Nebulizers are not as portable as inhalers, and it may be tough to bring them about with you. Inhalers, on the other hand, are often more compact and are more suited for traveling.
It is not necessary to take deep breaths or use your hands while inhaling through a nebulizer; in fact, there is no need for any kind of particular method at all; you may just breathe as you normally would. People of all ages, but especially younger children, the elderly, and those with restricted hand movement, may benefit much from this.
As a result of the fast increase in the average age of the population in the Middle East, which, given that aging is the primary risk factor for cancer, is leading to an increase in both the incidence and prevalence of cancer in all of the region's populations, these new changes pose significant obstacles for health care at both the national and neighborhood levels. In order to develop Dubai as a center of excellence for healthcare in the area, the government of the UAE is working toward increasing the number of tourists who come to the UAE for medical treatment. This provides further support for the expansion of the market throughout the time being projected.
The Jet market dominated the LAMEA Nebulizer Market by Type in 2021, achieving a market value of $66.1 Million by 2028. The Mesh market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The Ultrasonic market would witness a CAGR of 9.4% during (2022 - 2028).
Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on End-use, the market is segmented into Hospitals & Clinics, Emergency Centers and Home Healthcare. Based on Application, the market is segmented into COPD, Asthma, Cystic Fibrosis and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Koninklijke Philips N.V., Drive DeVilbiss Healthcare (Medical Depot, Inc.), Beurer GmBH, Vectura Group Plc (Philip Morris International, Inc.), Allied Healthcare Products, Inc., GE HealthCare Technologies, Inc., PARI GmbH, Aerogen Ltd.
It is not necessary to take deep breaths or use your hands while inhaling through a nebulizer; in fact, there is no need for any kind of particular method at all; you may just breathe as you normally would. People of all ages, but especially younger children, the elderly, and those with restricted hand movement, may benefit much from this.
As a result of the fast increase in the average age of the population in the Middle East, which, given that aging is the primary risk factor for cancer, is leading to an increase in both the incidence and prevalence of cancer in all of the region's populations, these new changes pose significant obstacles for health care at both the national and neighborhood levels. In order to develop Dubai as a center of excellence for healthcare in the area, the government of the UAE is working toward increasing the number of tourists who come to the UAE for medical treatment. This provides further support for the expansion of the market throughout the time being projected.
The Jet market dominated the LAMEA Nebulizer Market by Type in 2021, achieving a market value of $66.1 Million by 2028. The Mesh market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The Ultrasonic market would witness a CAGR of 9.4% during (2022 - 2028).
Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on End-use, the market is segmented into Hospitals & Clinics, Emergency Centers and Home Healthcare. Based on Application, the market is segmented into COPD, Asthma, Cystic Fibrosis and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Koninklijke Philips N.V., Drive DeVilbiss Healthcare (Medical Depot, Inc.), Beurer GmBH, Vectura Group Plc (Philip Morris International, Inc.), Allied Healthcare Products, Inc., GE HealthCare Technologies, Inc., PARI GmbH, Aerogen Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Jet
- Mesh
- Ultrasonic
By End-use
- Hospitals & Clinics
- Emergency Centers
- Home Healthcare
By Application
- COPD
- Asthma
- Cystic Fibrosis
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Omron Corporation
- Koninklijke Philips N.V
- Drive DeVilbiss Healthcare (Medical Depot, Inc.)
- Beurer GmBH
- Vectura Group Plc (Philip Morris International, Inc.)
- Allied Healthcare Products, Inc
- GE HealthCare Technologies, Inc
- PARI GmbH
- Aerogen Ltd
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Nebulizer Market, by Type
1.4.2 LAMEA Nebulizer Market, by End-use
1.4.3 LAMEA Nebulizer Market, by Application
1.4.4 LAMEA Nebulizer Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Nebulizer Market by Type
3.1 LAMEA Jet Market by Country
3.2 LAMEA Mesh Market by Country
3.3 LAMEA Ultrasonic Market by Country
Chapter 4. LAMEA Nebulizer Market by End-use
4.1 LAMEA Hospitals & Clinics Market by Country
4.2 LAMEA Emergency Centers Market by Country
4.3 LAMEA Home Healthcare Market by Country
Chapter 5. LAMEA Nebulizer Market by Application
5.1 LAMEA COPD Market by Country
5.2 LAMEA Asthma Market by Country
5.3 LAMEA Cystic Fibrosis Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Nebulizer Market by Country
6.1 Brazil Nebulizer Market
6.1.1 Brazil Nebulizer Market by Type
6.1.2 Brazil Nebulizer Market by End-use
6.1.3 Brazil Nebulizer Market by Application
6.2 Argentina Nebulizer Market
6.2.1 Argentina Nebulizer Market by Type
6.2.2 Argentina Nebulizer Market by End-use
6.2.3 Argentina Nebulizer Market by Application
6.3 UAE Nebulizer Market
6.3.1 UAE Nebulizer Market by Type
6.3.2 UAE Nebulizer Market by End-use
6.3.3 UAE Nebulizer Market by Application
6.4 Saudi Arabia Nebulizer Market
6.4.1 Saudi Arabia Nebulizer Market by Type
6.4.2 Saudi Arabia Nebulizer Market by End-use
6.4.3 Saudi Arabia Nebulizer Market by Application
6.5 South Africa Nebulizer Market
6.5.1 South Africa Nebulizer Market by Type
6.5.2 South Africa Nebulizer Market by End-use
6.5.3 South Africa Nebulizer Market by Application
6.6 Nigeria Nebulizer Market
6.6.1 Nigeria Nebulizer Market by Type
6.6.2 Nigeria Nebulizer Market by End-use
6.6.3 Nigeria Nebulizer Market by Application
6.7 Rest of LAMEA Nebulizer Market
6.7.1 Rest of LAMEA Nebulizer Market by Type
6.7.2 Rest of LAMEA Nebulizer Market by End-use
6.7.3 Rest of LAMEA Nebulizer Market by Application
Chapter 7. Company Profiles
7.1 Omron Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Koninklijke Philips N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Vectura Group plc (Philip Morris International, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.4.1 Partnerships, Collaborations, and Agreements:
7.4 Allied Healthcare Products, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Drive DeVilbiss Healthcare (Medical Depot, Inc.)
7.5.1 Company Overview
7.6 Beurer GmbH
7.6.1 Company Overview
7.7 GE HealthCare Technologies, Inc.
7.7.1 Company Overview
7.8 PARI GmbH
7.8.1 Company Overview
7.9 Aerogen Ltd.
7.9.1 Company Overview
Companies Mentioned
- Omron Corporation
- Koninklijke Philips N.V.
- Drive DeVilbiss Healthcare (Medical Depot, Inc.)
- Beurer GmBH
- Vectura Group Plc (Philip Morris International, Inc.)
- Allied Healthcare Products, Inc.
- GE HealthCare Technologies, Inc.
- PARI GmbH
- Aerogen Ltd.
Methodology
LOADING...
